Cargando…

An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial

BACKGROUND: The complex nature of the medical dialogue and the often emotional context in cancer care present challenges to health care professionals (HCPs) and patients. Patients are increasingly expected to be informed participants and to be able to make conscious decisions, which they often find...

Descripción completa

Detalles Bibliográficos
Autores principales: van Bruinessen, Inge Renske, van Weel-Baumgarten, Evelyn M, Gouw, Hans, Zijlstra, Josée M, van Dulmen, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982912/
https://www.ncbi.nlm.nih.gov/pubmed/27473173
http://dx.doi.org/10.2196/jmir.5877
_version_ 1782447832989433856
author van Bruinessen, Inge Renske
van Weel-Baumgarten, Evelyn M
Gouw, Hans
Zijlstra, Josée M
van Dulmen, Sandra
author_facet van Bruinessen, Inge Renske
van Weel-Baumgarten, Evelyn M
Gouw, Hans
Zijlstra, Josée M
van Dulmen, Sandra
author_sort van Bruinessen, Inge Renske
collection PubMed
description BACKGROUND: The complex nature of the medical dialogue and the often emotional context in cancer care present challenges to health care professionals (HCPs) and patients. Patients are increasingly expected to be informed participants and to be able to make conscious decisions, which they often find very difficult. In an attempt to support patients with malignant lymphoma in clinical communication, we developed a stand-alone, Web-based intervention called “PatientTIME.” The development of PatientTIME was based on a participatory intervention mapping framework. Its primary aim is to boost patients’ self-efficacy in patient-professional communication (ie, their confidence when interacting with their HCP). Patients can use this intervention before their hospital visit to prepare for their clinical consultation. PatientTIME is fully automated and use is patient-initiated. OBJECTIVE: The aim of this study was to evaluate if and in what way patients benefit from PatientTIME and if it enhances their confidence in clinical communication. METHODS: The intervention was evaluated in a closed randomized controlled trial with continuous recruitment (using online and offline methods to reach potential participants) and data collection. In accordance with the Medical Research Council guidance, we started with a process evaluation. Subsequently, an outcome evaluation was performed focusing on the patients’ perceived confidence in communication with their HCP, measured with the validated PEPPI questionnaire at baseline and at 3 months after participation. Process and outcome data were obtained through Web-based questionnaires, log files (automatically generated files mapping the interactions between program and users), and a logbook (comprising a record of actions and interactions kept by the researchers). Participants were not blinded. A total of 146 patients registered online, of whom 97 gave their informed consent and were assigned at random to the control group (N=34) or 1 of the 2 intervention groups (N=63). Ultimately 87/97 (90%) of these patients actually participated in the study, producing 87 datasets for analysis. RESULTS: More than half of the intervention group patients reported that the intervention helped them prepare for a clinical consultation; it created awareness about the importance of communication and reinforced their existing communication skills. In the postvisit test, the control group showed a small, nonsignificant improvement in perceived communication efficacy. The intervention group showed a significant improvement in perceived efficacy. However, the interaction effect was not significant, indicating that the improvement solely as a result of the intervention may not be significant. CONCLUSIONS: A considerable number of patients reported that PatientTIME did provide support. We found a trend indicating that in the long run, patients with access to PatientTIME scored better on the perceived efficacy scale than patients without access. However, at this stage we cannot conclude that PatientTIME improves patients’ confidence when interacting with HCPs. CLINICALTRIAL: Netherlands National Trial Register (NTR): 3779; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3779 (archived by WebCite at http://www.webcitation.org/6iztxJ5Nt)
format Online
Article
Text
id pubmed-4982912
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-49829122016-08-29 An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial van Bruinessen, Inge Renske van Weel-Baumgarten, Evelyn M Gouw, Hans Zijlstra, Josée M van Dulmen, Sandra J Med Internet Res Original Paper BACKGROUND: The complex nature of the medical dialogue and the often emotional context in cancer care present challenges to health care professionals (HCPs) and patients. Patients are increasingly expected to be informed participants and to be able to make conscious decisions, which they often find very difficult. In an attempt to support patients with malignant lymphoma in clinical communication, we developed a stand-alone, Web-based intervention called “PatientTIME.” The development of PatientTIME was based on a participatory intervention mapping framework. Its primary aim is to boost patients’ self-efficacy in patient-professional communication (ie, their confidence when interacting with their HCP). Patients can use this intervention before their hospital visit to prepare for their clinical consultation. PatientTIME is fully automated and use is patient-initiated. OBJECTIVE: The aim of this study was to evaluate if and in what way patients benefit from PatientTIME and if it enhances their confidence in clinical communication. METHODS: The intervention was evaluated in a closed randomized controlled trial with continuous recruitment (using online and offline methods to reach potential participants) and data collection. In accordance with the Medical Research Council guidance, we started with a process evaluation. Subsequently, an outcome evaluation was performed focusing on the patients’ perceived confidence in communication with their HCP, measured with the validated PEPPI questionnaire at baseline and at 3 months after participation. Process and outcome data were obtained through Web-based questionnaires, log files (automatically generated files mapping the interactions between program and users), and a logbook (comprising a record of actions and interactions kept by the researchers). Participants were not blinded. A total of 146 patients registered online, of whom 97 gave their informed consent and were assigned at random to the control group (N=34) or 1 of the 2 intervention groups (N=63). Ultimately 87/97 (90%) of these patients actually participated in the study, producing 87 datasets for analysis. RESULTS: More than half of the intervention group patients reported that the intervention helped them prepare for a clinical consultation; it created awareness about the importance of communication and reinforced their existing communication skills. In the postvisit test, the control group showed a small, nonsignificant improvement in perceived communication efficacy. The intervention group showed a significant improvement in perceived efficacy. However, the interaction effect was not significant, indicating that the improvement solely as a result of the intervention may not be significant. CONCLUSIONS: A considerable number of patients reported that PatientTIME did provide support. We found a trend indicating that in the long run, patients with access to PatientTIME scored better on the perceived efficacy scale than patients without access. However, at this stage we cannot conclude that PatientTIME improves patients’ confidence when interacting with HCPs. CLINICALTRIAL: Netherlands National Trial Register (NTR): 3779; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3779 (archived by WebCite at http://www.webcitation.org/6iztxJ5Nt) JMIR Publications 2016-07-29 /pmc/articles/PMC4982912/ /pubmed/27473173 http://dx.doi.org/10.2196/jmir.5877 Text en ©Inge Renske van Bruinessen, Evelyn M van Weel-Baumgarten, Hans Gouw, Josée M Zijlstra, Sandra van Dulmen. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 29.07.2016. https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/ (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
van Bruinessen, Inge Renske
van Weel-Baumgarten, Evelyn M
Gouw, Hans
Zijlstra, Josée M
van Dulmen, Sandra
An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial
title An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial
title_full An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial
title_fullStr An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial
title_full_unstemmed An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial
title_short An Integrated Process and Outcome Evaluation of a Web-Based Communication Tool for Patients With Malignant Lymphoma: Randomized Controlled Trial
title_sort integrated process and outcome evaluation of a web-based communication tool for patients with malignant lymphoma: randomized controlled trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982912/
https://www.ncbi.nlm.nih.gov/pubmed/27473173
http://dx.doi.org/10.2196/jmir.5877
work_keys_str_mv AT vanbruinesseningerenske anintegratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT vanweelbaumgartenevelynm anintegratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT gouwhans anintegratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT zijlstrajoseem anintegratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT vandulmensandra anintegratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT vanbruinesseningerenske integratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT vanweelbaumgartenevelynm integratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT gouwhans integratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT zijlstrajoseem integratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial
AT vandulmensandra integratedprocessandoutcomeevaluationofawebbasedcommunicationtoolforpatientswithmalignantlymphomarandomizedcontrolledtrial